Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
21.07
+0.27 (1.30%)
Jul 31, 2025, 2:29 PM - Market open

Dianthus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21
678645154--
Market Cap Growth
-33.81%318.69%---
Enterprise Value
339364-35--
Last Close Price
20.8021.8010.40--
PS Ratio
114.28103.4854.53--
PB Ratio
2.031.830.91--
P/TBV Ratio
2.041.830.91--
EV/Sales Ratio
51.9358.45---
Debt / Equity Ratio
0.000.000.000.01-
Asset Turnover
0.020.020.020.14-
Quick Ratio
15.5914.9618.099.861.70
Current Ratio
15.9915.2218.439.971.75
Return on Equity (ROE)
-28.73%-32.60%-35.92%-73.25%-
Return on Assets (ROA)
-20.04%-23.01%-22.94%-40.12%-
Return on Capital (ROIC)
-20.83%-24.33%-24.69%-47.27%-
Earnings Yield
-15.06%-13.17%-28.26%--
FCF Yield
-13.60%-12.13%-23.99%--
Buyback Yield / Dilution
-215.78%-546.44%-489.48%78.17%-
Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q